What's new

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

May 14, 2025 - 13:46
 0
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Entresto, sacubitril,v...

Next Article

PMF dossier requirements - Questions and answers for PMF holders

Related Posts

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 7, 2025  0

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0